Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.69 USD
Change Today 0.00 / 0.00%
Volume 75.2K
PIP On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen B. Calderwood M.D.

Member of Scientific Advisory Board, PharmAthene, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Stephen B. Calderwood MD serves as Advisor of Pulmatrix Inc. Dr. Calderwood serves as Chief of Division of Infectious Diseases of Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. He serves as a Member of Scientific Advisory Board of Pharmathene, Inc. Dr. Calderwood did his under graduation from Harvard University and got his medical training from Harvard Medical School.

Corporate Headquarters*

One Park Place
Annapolis, Maryland 21401

United States

Phone: 410-269-2600
Fax: 410-269-2601

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PIP:US $1.69 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$419.3K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Anthony S. Marucci M.B.A.Founder, Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$814.1K
Peter Mørch Eriksen BBAChief Executive Officer and Administration Director
BioPorto A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMATHENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.